We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
-11.56%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$6.29B
AUM Growth
-$974M
Cap. Flow
-$40.2M
Cap. Flow %
-0.64%
Top 10 Hldgs %
18.7%
Holding
388
New
9
Increased
114
Reduced
196
Closed
16

Sector Composition

Rank Sector Weight
1 Financials 18.05%
2 Healthcare 16.64%
3 Technology 15.68%
4 Industrials 13.25%
5 Consumer Staples 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWM icon
101
iShares Russell 2000 ETF
IWM
$79.8B
$18M 0.29%
134,250
+125,471
+1,429% +$18.7M
BRKR icon
102
Bruker
BRKR
$9.57B
$17.9M 0.29%
602,820
-187,469
-24% -$5.92M
SLGN icon
103
Silgan Holdings
SLGN
$4.23B
$17.8M 0.28%
752,883
-45,150
-6% -$1.14M
HRC
104
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$17.7M 0.28%
199,380
+49,743
+33% +$4.52M
FDS icon
105
Factset
FDS
$9.36B
$17.1M 0.27%
85,688
+7,476
+10% +$1.65M
MNRO icon
106
Monro
MNRO
$383M
$16.9M 0.27%
246,299
-9,632
-4% -$704K
XRAY icon
107
Dentsply Sirona
XRAY
$2.68B
$16.8M 0.27%
451,893
-133,039
-23% -$4.84M
HON icon
108
Honeywell
HON
$77B
$16.5M 0.26%
132,305
-44,978
-25% -$6.14M
TEL icon
109
TE Connectivity
TEL
$59.6B
$16.5M 0.26%
217,520
+21,120
+11% +$1.63M
NDSN icon
110
Nordson
NDSN
$16.6B
$16.1M 0.26%
135,263
+11,100
+9% +$1.36M
CRL icon
111
Charles River Laboratories
CRL
$11.2B
$16.1M 0.26%
142,177
-7,136
-5% -$893K
IFF icon
112
International Flavors & Fragrances
IFF
$20.2B
$15.8M 0.25%
117,885
+13,225
+13% +$1.83M
EAT icon
113
Brinker International
EAT
$9.17B
$15.8M 0.25%
359,841
-5,051
-1% -$240K
ACC
114
DELISTED
American Campus Communities, Inc.
ACC
$15.8M 0.25%
381,871
+291,841
+324% +$12.1M
CSGS
115
DELISTED
CSG Systems International
CSGS
$15.8M 0.25%
496,607
+49,386
+11% +$1.73M
TECH icon
116
Bio-Techne
TECH
$11.2B
$15.7M 0.25%
434,252
-160,388
-27% -$6.7M
BIG
117
DELISTED
Big Lots, Inc.
BIG
$15.6M 0.25%
539,321
-42,413
-7% -$1.65M
CNS icon
118
Cohen & Steers
CNS
$4.23B
$15.4M 0.25%
449,206
-7,161
-2% -$265K
HAE icon
119
Haemonetics
HAE
$3.89B
$15.2M 0.24%
152,406
-67,955
-31% -$7.14M
COO icon
120
Cooper Companies
COO
$14.1B
$15M 0.24%
235,192
+19,336
+9% +$1.25M
MORN icon
121
Morningstar
MORN
$7.22B
$14.9M 0.24%
135,946
-30,241
-18% -$3.54M
APA icon
122
APA Corp
APA
$13.2B
$14.8M 0.24%
564,364
-10,449
-2% -$385K
INVX
123
Innovex International
INVX
$1.96B
$14.6M 0.23%
485,904
+80,783
+20% +$3.26M
IDCC icon
124
InterDigital
IDCC
$7.87B
$14.4M 0.23%
217,110
-9,428
-4% -$687K
JLL icon
125
Jones Lang LaSalle
JLL
$16.3B
$14.3M 0.23%
113,081
+12,958
+13% +$1.75M

Similar funds

Boston Trust Walden's Q4 2018 Portfolio in Review

As of Q4 2018, Boston Trust Walden held 388 positions worth $6.29B, down 13% from $7.26B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Boston Trust Walden's Q4 2018 filing shows 9 new, 114 increased, 196 reduced and 16 closed positions. Its largest new stake was Linde: 155,172 shares worth $24.2M. The largest sale was Praxair Inc, an estimated $29.2M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Technology.

  • Boston Trust Walden's largest Q4 2018 buy was Linde: 155,172 shares worth $24.2M.
  • Boston Trust Walden added most to iShares Russell 2000 ETF in Q4 2018, an estimated $18.7M increase.
  • Boston Trust Walden's biggest Q4 2018 reduction was PPG Industries, cutting an estimated $10.3M.
  • Boston Trust Walden fully exited Praxair Inc in Q4 2018, selling an estimated $29.2M.
  • Boston Trust Walden's ten largest holdings make up 19% of its $6.29B portfolio in Q4 2018.
  • Boston Trust Walden opened 9 new positions and closed 16 in Q4 2018.
  • Boston Trust Walden's portfolio value fell 13% quarter-over-quarter to $6.29B.

Based on Boston Trust Walden's 13F filing for Q4 2018, filed 17 Jan 2019.